US Patent Litigations are now available. Check here

Explore Xellia Pharmaceuticals Aps's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3215173Mar 11, 2020Glycopeptide Compositions1